logo-loader
viewCann Global Ltd

Cann Global re-lists and starts afresh in medical marijuana space

Cann Global re-lists and starts afresh in medical marijuana space

Cann Global Ltd (ASX:CGB) managing director Sholom Feldman updates Proactive Investors on the company’s exciting transformation from a mining company into the medical cannabis space.

The company has recently been relisted on the Australian Stock Exchange and has raised revenue to help support the new focus, strategy and growth.

Impressive results are already being seen in the company’s hemp food division, medical research with a Israeli University and a joint venture with international health and wellness company Pharmacan.

Quick facts: Cann Global Ltd

Price: 0.013 AUD

ASX:CGB
Market: ASX
Market Cap: $41.96 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Xpediator's Stephen Blyth outlines five-year growth plans as core businesses...

Xpediator PLC's (LON:XPD) Stephen Blyth speaks to Proactive London following the release of its 2019 trading update. The firm saw turnover rise 19% to £212mln - boosted by acquisitions and organic growth while adjusted pre-tax profit's expected to be slightly above £5mln. Blyth says a big...

2 days, 13 hours ago

2 min read